PSIG:NASDAQPS International Group Ltd. Analysis
Data as of 2026-05-19 - not real-time
$7.62
Latest Price
8/10Risk
Risk Level: High
Executive Summary
PSIG is trading in a strong technical uptrend, with the 20‑day SMA (≈$6.69) comfortably above the 50‑day SMA (≈$6.29) and the 200‑day SMA (≈$4.76), and the MACD line sitting bullish above its signal. Momentum is high – the 14‑day RSI is near 71, indicating the stock is overbought, and volume is on an increasing trend, supporting the current price rally toward the $7.78 resistance.
However, the fundamentals paint a starkly different picture: revenue has collapsed by 41%, gross and operating margins are deeply negative, trailing EPS is –$3.81, and the DCF‑derived fair value of roughly $2.10 is less than one‑third of the current market price of $7.62. The company also shows a high 30‑day volatility of over 52% and a modest beta of 0.64, underscoring significant price swings despite a relatively lower market‑wide correlation. In short, bullish technical signals are fighting against a backdrop of deteriorating earnings, weak cash generation, and a valuation that appears stretched far beyond intrinsic estimates.
However, the fundamentals paint a starkly different picture: revenue has collapsed by 41%, gross and operating margins are deeply negative, trailing EPS is –$3.81, and the DCF‑derived fair value of roughly $2.10 is less than one‑third of the current market price of $7.62. The company also shows a high 30‑day volatility of over 52% and a modest beta of 0.64, underscoring significant price swings despite a relatively lower market‑wide correlation. In short, bullish technical signals are fighting against a backdrop of deteriorating earnings, weak cash generation, and a valuation that appears stretched far beyond intrinsic estimates.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Technical overbought condition (RSI ~71)
- Proximity to resistance level at $7.78
- Weak earnings and negative margins
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair value far below market price
- Sustained revenue decline and loss making
- High volatility and limited cash cushion
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Persistent negative profitability and cash flow
- Valuation disconnect from intrinsic value
- Elevated risk profile across sector, geography and liquidity
Key Metrics & Analysis
Financial Health
Revenue Growth-41.10%
Profit Margin-6.76%
ROE-40.74%
ROA-19.51%
Debt/Equity0.72
P/B Ratio2.3
Op. Cash Flow$-423659
Free Cash Flow$2.0M
Industry P/E29.2
Technical Analysis
TrendBullish
RSI70.7
Support$6.15
Resistance$7.78
MA 20$6.69
MA 50$6.29
MA 200$4.76
MACDBullish
VolumeIncreasing
Fear & Greed Index89.3
Valuation
Fair Value$2.11
GradeOvervalued
TypeValue
Risk Assessment
Beta0.64
Volatility52.20%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.